7210 Wareham Drive, Tampa, FL 33647
Nov. 4, 2025 Management reported the foillowing: Revenue: $89.4 million, with revenue per active earning coach of $4,585 Active Coaches: Independent active earning OPTA VIA ® coaches of 19,500 Net Loss: $2.3 million or $0.21 loss per diluted share Strong Balance Sheet: $173.5 million in cash, cash equivalents, and investment securities with no debt “We’re transforming Medifast from a […]
Medifast Reports Q3 Results – Slide Continues Read More »
April 30, 2025 Herbalife today reported its first quarter 2025 results. The company sells a significant amount of weight management products (meal replacements), and is one the the leading MLM companies selling weight loss products. At $254.4 million, North American sales represented 20.8% of total Herbalife revenues for the quarter. The company had worldwide weight
Herbalife Reports Q1 2025 Results Read More »
April 28, 2025 According to CEO Dan Chard: “This year, we are focused on revitalizing our coach and customer base by supporting them with enhanced tools, data, and new products. Our business focus remains on reestablishing sustainable long-term growth while improving profitability.” First quarter 2025 revenue decreased 33.8% to $115.7 million from $174.7 million for the
Medifast Reports First Quarter Results – Slide Continues Read More »
Nov. 4, 2024 Medifast reported Q3 results today. CEO Dan Chard said: “With tailored plans, personal solutions and a focused approach to driving customer acquisition, we believe that our strategy can drive sustainable growth in the quarters and years ahead.” Third Quarter 2024 Revenue of $140.2 million, with revenue per active earning coach of $4,672
Medifast Reports 3rd Quarter Results Read More »
August 5, 2024 Wellness company Medifast (NYSE:MED) fell short of analysts’ expectations. Management said that: “We are acting decisively to transform our business to position us for long-term growth, with a strong balance sheet free of debt, a clear focus on new customer acquisition, and a broader health and wellness offer to a significantly expanded
Medifast Reports Q2 Results Read More »
Feb. 20, 2024 Medifast reported full-year and Q4 results on February 20, 2023. 2023 revenues came in at $1.07 billion. The company employed 41,100 active earning Optavia health coaches, who had quarterly earnings of $4,648 (or $18,592 on an annual rate). Management said that: “We are realigning our business to respond to the evolving dynamics
Medifast Reports Q4 and Full Year 2023 Results Read More »
Jan. 11, 2024 The pandemic had significant effects on the way commercial weight loss companies operate, along with the explosive demand for GLP-1 obesity drugs such as Ozempic, Wegovy, and Mounjaro. Marketdata estimates that between Medifast, Weight Watchers, Jenny Craig, and Noom, at least 26,500 weight loss coaches have lost their jobs since 2020. Here’s
Ozempic Boom Is Hurting Weight Loss Coaches Read More »
Dec. 30, 2023 We have started to see TV commercials touting a company called RO, for weight loss. Apparently, this company entered the weight loss market in January 2023, providing GLP-1 weight loss drugs plus coaching, Ro is a direct-to-patient healthcare company with a mission of helping patients achieve their health goals by delivering the
New Competitor – RO.co (Roman Health Ventures) Read More »
Feb. 24, 2022 Herbalife is a significant seller of meal replacements and weight management products such as shakes and nutrition bars, as well as appetite suppressants. It is one of the few public MLM companies for which we can obtain actual sales (along with Glanbia and Nu-Skin). The North America region reported net sales of
Herbalife Reports Q4 and Full Year 2021 Results Read More »
May 19, 2021 Noom Inc., a popular app targeted to help weight loss, is said to have obtained funding from the private equity firm Silver Lake ahead of a potential IPO. Noom is said to be worth $4 billion in its latest funding round, according to a Bloomberg report yesterday. The company, which hopes to be
Noom, Weight Loss App Company, Eyes Possible IPO Read More »